Back to results
US 6,638,928 B1Granted
Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
AssigneeVela Pharmaceuticals, Inc.
InventorsHerbert W. Harris, Robert F. Kucharik
Life of this patent
Estimating the term…
Abstract
Compounds according to formula I: are disclosed wherein R1, R2, R3, R4, R5 and R6 as defined herein, are administered for irritable bowel syndrome and nonulcer dyspepsia.
Claims13
A method of treating or preventing irritable bowel syndrome or nonulcer dyspepsia in an individual in need of such treatment, comprising administering to the individual an effective amount of at least one compound according to formula I:
- wherein:
- R1 is —(C1-C7)hydrocarbyl or —(C2-C6)heteroalkyl;
- R2 is —H or —(C1-C7)hydrocarbyl;
- wherein R1 and R2 may combine to form a carbocyclic 5-or 6-membered ring;
- one of phenyl substituents R3, R4, R5 or R6 is —OH and the remaining phenyl substituents R3, R4, R5 or R6 are independently selected from the group consisting of —(C1-C7)hydrocarbyl, —CF3, —O(C1-C7)hydrocarbyl, —O-acyl, —NH2, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, —NH-acyl and halogen;
- * denotes a chiral carbon;
- wherein the bond designated by indicates that the absolute conformation about the chiral carbon may be either (R) or (S);
- or a pharmaceutically-acceptable salt of such a compound.
5 more elements
Dependencies are inferred from the claim text.